Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07193290 · ClinicalTrials.gov registry record
A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies
A clinical trial, sponsored by Kenvue Brands.
- Completed
- Registry status
- 1,027
- Enrollment target
NCT07193290: Completed study, sponsored by Kenvue Brands.
NCT07193290 is a clinical trial that has completed, run by Kenvue Brands. The registered enrollment target is 1,027 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07193290 has completed, sponsored by Kenvue Brands.
- COMPLETED
- Registry status
- 1,027 participants
- Enrollment target
Study Summary
This is a randomized, decentralized, non-interventional clinical study. The primary objective of this study is to develop execution and efficiency metrics from completion of this study to inform on the potential design for future projects. The secondary objective of this study is to assess the main study endpoints across balanced attributes of study sub-populations.
Primary Outcome
The number and percentage of subjects who interacted with the digital study activities vs number and percentage of subjects who completed the study.
Interventions
- OTHER Lifestyle Questionnaire
- OTHER Self-portrait image (Face and Hair)
- DIAGNOSTIC_TEST Skin microbiome collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,027 participants |
| Start Date | 2025-05-13 |
| Est. Completion | 2025-10-01 |
What the finished NCT07193290 record still lists
NCT07193290 is an observational study that tracks outcomes without assigning an intervention. Its 1,027 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 3 interventions - of which Lifestyle Questionnaire is the first listed.
NCT07193290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07193290 about?
NCT07193290 is a clinical study titled "A Pilot Study to Evaluate the Expanded Reach of Decentralized Digital Skin Health Clinical Studies". This is a randomized, decentralized, non-interventional clinical study. The primary objective of this study is to develop execution and efficiency metrics from completion of this study to inform on the potential design for future projects. The secondary objective of this study is to assess the main ...
What is the current status of trial NCT07193290?
This trial is currently completed. The enrollment target is 1,027 participants. The study started on 2025-05-13. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT07193290?
The interventions under investigation include: Lifestyle Questionnaire (OTHER), Self-portrait image (Face and Hair) (OTHER), Skin microbiome collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07193290?
This trial is sponsored by Kenvue Brands, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI